The phase II study of hypo-fractionated proton beam therapy for mucosal melanoma of the head and neck

The phase II study of hypo-fractionated proton beam therapy for mucosal melanoma of the head and neck - MM proton P-II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001505

Enrollment

Registered

2009-07-03

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucosal melanoma of the head and neck

Interventions

Proton beam therapy 60GyE/15fr/5w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Histologically confirmed mucosal melanoma 2.nasal or paranasal mucosal melanoma 3.N0 and M0 4.PS(ECOG):0-2 5.adequate organ function

Exclusion criteria

Exclusion criteria: 1.with active other carcinoma 2.with mental disorder 3.recieve systemic steroid therapy 4.with active infectious disease

Design outcomes

Primary

Measure	Time frame
Local control rate	—

Secondary

Measure	Time frame
Overall survival Acute toxicity Late toxicity	—

Countries

Japan

Contacts

Public ContactSadamoto Zenda

National Cancer Center Hospital East Division of Radiation Oncology

szenda@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026